Tradestie Institutional Equity Comparison Engine

PACS vs SGRY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PACS Overall Edge

PACS Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PACS Group, Inc. (PACS) driven by superior Valuation, Growth & Margin, Options & Structure while SGRY counters with relative strength in Momentum & Technical. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus SGRY at N/M Forward P/E and 13.2% operating margin (-0.8% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PACS
PACS 15.3x vs SGRY N/M Fwd P/E
Growth & Margin Winner PACS
Op Margin 7.4% vs 13.2% ยท YoY +11.5% vs -0.8%
Momentum & Technical Winner SGRY
1Y +159.5% vs +70.5% ยท 52W Pos 79% vs 97%
Options & Structure Winner PACS
CONSOLIDATION (11th %ile IV) vs SURGE (34th %ile IV)
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
1M Return -8.06%
1Y Return +159.48%
Forward P/E 15.3x
Unified AI Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
SGRY NASDAQ
Surgery Partners, Inc. Common Stock
Services-General Medical & Surgical Hospitals, Nec
$26.78
+0.34% 1D
Market Cap $3.5B
1M Return +68.43%
1Y Return +70.46%
Forward P/E N/M
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 24.0 Flow 56.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACS +159.48% SGRY +70.46% Spread: +89.02 pp (PACS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACS Revenue SGRY Revenue PACS Op. Margin SGRY Op. Margin Margin Edge
FY2018 N/A $1.77B N/A 4.4% SGRY
FY2019 N/A $1.83B N/A 12.9% SGRY
FY2020 N/A $1.86B N/A 9.8% SGRY
FY2021 N/A $2.23B N/A 13.6% SGRY
FY2022 $2.40B $2.54B 9.6% 13.6% SGRY
FY2023 $3.11B $2.74B 6.7% 12.0% SGRY
FY2024 $4.09B $3.11B 3.0% 11.2% SGRY
FY2025 $5.29B $3.31B 5.9% 11.8% SGRY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACS (8) vs SGRY (2)
Institutional Metric PACS SGRY Criterion Row Winner
Market Capitalization Scale $6.8B $3.5B Larger Scale PACS
Trailing P/E Ratio Valuation 26.2x N/M Lower Multiple PACS
Forward P/E Ratio Valuation 15.3x N/M Lower Multiple PACS
Revenue Growth (YoY) Growth +11.5% -0.8% Higher Growth PACS
Operating Margin (TTM) Profitability 7.4% 13.2% Higher Margin SGRY
Net Profit Margin Profitability 4.9% -2.6% Higher Margin PACS
Return on Equity (ROE) Capital Efficiency 26.5% 2.1% Higher ROE PACS
52-Week Range Position Momentum 79% ($14โ€“$52) 97% ($11โ€“$27) Stronger Trend SGRY
Beta / 30D Volatility Risk Regime 0.78ฮฒ ยท 51% Vol 0.87ฮฒ ยท 166% Vol Lower Realized Risk PACS
Unified Institutional Score Composite Signal 46.8 / 100 (HOLD) 29.6 / 100 (SELL) Higher Composite PACS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACS vs SGRY Buy Guide
PACS CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PACS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGRY SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SGRY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACS nor SGRY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.